Clinical Trial Update: Treatment Protocol of Plozasiran in Adults With High-Risk Severe Hypertriglyceridemia (SHTG) and in Adults and Adolescents With FCS

View source ↗

Summary

ClinicalTrials.gov update describes the treatment protocol for the investigational drug Plozasiran in adults with high-risk severe hypertriglyceridemia and in a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Familial Chylomicronemia Syndrome
• Hypertriglyceridemia

Drugs mentioned

• Plozasiran

Snippet

Sponsor: Arrowhead Pharmaceuticals | Conditions: Familial Chylomicronemia, High Risk Severe Hypertriglyceridemia (SHTG) | Status: AVAILABLE